<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05618106</url>
  </required_header>
  <id_info>
    <org_study_id>FODMAP</org_study_id>
    <nct_id>NCT05618106</nct_id>
  </id_info>
  <brief_title>Low FODMAP Diet in Patients With IBS</brief_title>
  <official_title>Modification of the Low FODMAP Diet in Treatment of Irritable Bowel Syndrome: A Randomised Cross-over Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jens Rikardt Andersen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aimed to investigate if all carbohydrate groups eliminated in the Low FODMAP diet are&#xD;
      equally important in relieving gastrointestinal symptoms in IBS.&#xD;
&#xD;
      in a randomised cross-over design to three different carbohydrate-modified diets: A) Low&#xD;
      Polyol diet, B) Low FOS+GOS diet, and C) Low FODMAP diet for three months without&#xD;
      wash-out-periods. Gastrointestinal symptoms, Quality of life was measured at baseline and&#xD;
      after each intervention diet.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low FODMAP diets contain 3 major types of carbohydrates to be avoided. The clasical diet is&#xD;
      very difficult to maintain over longer periods of time. Therefore, we aimed to investigate if&#xD;
      all carbohydrate groups in the Low FODMAP diet are equally important in relieving&#xD;
      gastrointestinal symptoms in IBS.&#xD;
&#xD;
      Patients diagnosed with IBS according to the Rome III criteria were randomised in a&#xD;
      cross-over design to three different carbohydrate-modified diets: A) Low Polyol diet, B) Low&#xD;
      FOS+GOS diet, and C) Low FODMAP diet for a total of three months without wash-out-periods.&#xD;
      Gastrointestinal symptoms were assessed by the Birmingham IBS questionnaire and adequate&#xD;
      relief (IBS-AR). Quality of life was measured by the IBS Quality of Life Scale questionnaire&#xD;
      (IBS-QOL). All registrations were performed at baseline and after each intervention diet.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">February 1, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Cross-over of 3 variations of the low FODMAP diet excluding 1 of the 3 components in every period</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Birmingham IBS questionnaire and adequate relief (IBS-AR).</measure>
    <time_frame>3 months</time_frame>
    <description>Score in points</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IBS Quality of Life Scale questionnaire (IBS-QOL)</measure>
    <time_frame>3 months</time_frame>
    <description>Score in points</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>low FODMAP diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cross-over design with 3 variations</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>variations of the low FODMAP diet</intervention_name>
    <description>Cross-over of 3 interventions in IBS patients:&#xD;
Low Polyol diet&#xD;
Low FOS+GOS diet&#xD;
Low FODMAP diet</description>
    <arm_group_label>low FODMAP diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: IBS diagnosed by the Rome III criteria and referred to treatment by&#xD;
        diet -&#xD;
&#xD;
        Exclusion Criteria: Dementia, and lack of ability to speak Danish or other conditions&#xD;
        prevailing participation&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens R Andersen, MD, MPA</last_name>
    <role>Study Chair</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <state>Frederiksberg</state>
        <zip>1958</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 8, 2022</study_first_submitted>
  <study_first_submitted_qc>November 8, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>November 8, 2022</last_update_submitted>
  <last_update_submitted_qc>November 8, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Jens Rikardt Andersen</investigator_full_name>
    <investigator_title>Assoc Prof</investigator_title>
  </responsible_party>
  <keyword>Carbohydrates</keyword>
  <keyword>low FODMAP diet</keyword>
  <keyword>components in the low FODMAP diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

